Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2020
Same author

Combined use of rosuvastatin and ezetimibe improves hepatic steatosis in patients with dyslipidemia.

European journal of gastroenterology & hepatology·2020
Same author

Genetically Engineered Mouse Models for Liver Cancer.

Cancers·2019
Same author

Intraindividual Comparison between Gadoxetate-Enhanced Magnetic Resonance Imaging and Dynamic Computed Tomography for Characterizing Focal Hepatic Lesions: A Multicenter, Multireader Study.

Korean journal of radiology·2019
Same author

Retrospective comparison of EASL 2018 and LI-RADS 2018 for the noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging.

Hepatology international·2019
Same author

Comparison of Renal Function Estimation Formulae for Dosing Direct Oral Anticoagulants in Patients with Atrial Fibrillation.

Journal of clinical medicine·2019

Related Experiment Video

Updated: Apr 17, 2026

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
05:33

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

2.5K

Multiple milia formation induced by dovitinib.

Dongyun Shin1, Jimyung Seo, Soo Min Kim

  • 1Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea.

The Journal of Dermatology
|February 17, 2015
PubMed
Summary

Dovitinib, a cancer drug, can cause milia, a type of non-inflammatory skin cyst. This study reports two cases of milia formation linked to dovitinib treatment.

Keywords:
anticancer drug side-effectscutaneous side-effectsdovitinibmiliamilium

More Related Videos

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
09:14

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on: August 11, 2011

16.4K
Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy
09:17

Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy

Published on: September 16, 2019

7.4K

Related Experiment Videos

Last Updated: Apr 17, 2026

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
05:33

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

2.5K
An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
09:14

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on: August 11, 2011

16.4K
Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy
09:17

Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy

Published on: September 16, 2019

7.4K

Area of Science:

  • Oncology
  • Dermatology
  • Pharmacology

Background:

  • Dovitinib is a multi-target tyrosine kinase inhibitor investigated for various cancers.
  • Previous trials noted cutaneous adverse events in 20% of patients receiving dovitinib for renal cell carcinoma.
  • The specific type of skin rash associated with dovitinib has not been well-documented.

Observation:

  • This report details two cases of patients who developed multiple milia.
  • Milia are small, non-inflammatory, white or yellowish cysts on the skin.
  • These cases specifically highlight milia formation as a potential adverse event.

Findings:

  • Dovitinib treatment was associated with the development of multiple milia in two patients.
  • The observed milia were characterized as non-inflammatory cystic structures.
  • This represents the first report focusing on dovitinib-induced milia.

Implications:

  • Milia formation should be considered a potential cutaneous adverse event of dovitinib therapy.
  • Further investigation into the dermatological side effects of dovitinib is warranted.
  • This finding may inform clinical monitoring and patient counseling during dovitinib treatment.